eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | glanzmann thrombasthenia |
| Symptom | C0019080|hemorrhage |
| Sentences | 1 |
| PubMedID- 25065398 | Recombinant activated factor vii (rfviia) is currently approved for treating or preventing hemorrhage in patients with hemophilia, glanzmann's thrombasthenia, or congenital fvii deficiency. |
Page: 1